Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009176HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018522HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10005009HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10006865HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018417HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017628HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017629HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017826HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10011803HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018523HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807